In addition, after treatment with baicalin, the expression levels of Toll-like receptor 4 (TLR4), NF-κB, p65, and p-IκBα in CRC cells were significantly downregulated, and the inhibitory effect was weakened after the use of a TLR4 activator. The gene discussed is TLR4; the disease is colorectal carcinoma.